OCD in People With Autism Spectrum Disorders

Ailsa Russell, PhD
Clinical Director for the Doctorate in Clinical Psychology
University of Bath

Dr. Russell addresses treatment approaches for people with OCD and autism spectrum disorders. Her research with colleagues at Kings College London has focused on studies of people with autism, in particular trying to adapt or develop effective psychological interventions for anxiety, OCD, and other emotional disorders.

3rd Annual Clinical Practice Symposium

Complex Cases: PTSD, OCD, and Substance Abuse.

Friday, April 7, 2017

8:00 – 10:00 am

Our annual clinical symposium will feature a panel of expert clinicians working on a very complex case: an adult client struggling with PTSD, OCD, and substance abuse. Complex cases are not the exception but the norm in the therapy room. One can feel stuck trying to figure out how to approach these clients without a case formulation and a solid treatment plan. However, complex cases often create challenges to our formulations and interventions.

CBT and Psychopharmacology for OCD

Peggy Richter, MD

  • Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute
  • Head, Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Sciences Centre 
  • Director, Clinic for OCD & Related Disorders, Sunnybrook Health Sciences Centre
  • Affiliate scientist, Neurosciences Department, Centre for Addiction and Mental Health
  • Associate Professor, department of psychiatry, University of Toronto
  • Associate Member, graduate faculty, Institute of Medical Science, University of Toronto

Dr. Richter describes how CBT and various medication options can help treat people with OCD.

Tapering OCD Pharmacotherapy Support (TOPS) Study

Eligibility Criteria

Adults with OCD who wish to stop taking long-term (2 years or more) SRI medication may be eligible to participate. 

State
Rhode Island

The aim of the TOPS Study is evaluate the discontinuation of long-term serotonin reuptake inhibitors (SRIs) in individuals with obsessive-compulsive disorder (OCD).  

Participation in TOPS involves an initial screening appointment to ensure eligibility that includes completion of interviews and questionnaires. 

Eligible individuals are then randomly assigned to one of two 22-week programs using different techniques to help people come off medication.

All study participants will receive